FAVORABLE EFFECTS OF L-ARGININE ON ARTERIAL FUNCTION, INFLAMMATORY AND FIBRINOLYTIC PROCESS IN SMOKERS  by Siasos, Gerasimos et al.
A157.E1473
JACC Maarch 9, 2010
Volume 55, issue 10A
 VASCULAR DISEASE
FAVORABLE EFFECTS OF L-ARGININE ON ARTERIAL FUNCTION, INFLAMMATORY AND FIBRINOLYTIC 
PROCESS IN SMOKERS
ACC Poster Contributions
Georgia World Congress Center, Hall B5
Sunday, March 14, 2010, 9:30 a.m.-10:30 a.m.
Session Title: Peripheral Arterial/Carotid Disease/Aortic Disease
Abstract Category: Peripheral Arterial/Carotid Disease/Aortic Disease
Presentation Number: 1056-354
Authors: Gerasimos Siasos, Dimitris Tousoulis, Charalampos Vlachopoulos, Elias Gialafos, Evaggelos Oikonomou, Aris Plastiras, Marina Zaromitidou, 
Konstantinos Zisimos, Charalampos Antoniades, Georgia Siasou, Dimitra Papaspiridi, Georgios Marinos, Athanasios G. Papavassiliou, Christodoulos 
Stefanadis, Hippocration General Hospital of Athens, Athens Univercity Medical School, Athens, Greece
Background: Smoking is associated with impaired vascular function and increased inflammatory status. We investigated the effect of l-arginine on 
vascular function inflammatory process and fibrinolytic system in smokers.
Methods: We studied the effect of a 3-day oral administration of l-arginine in 12 healthy smokers (24±3yrs) on 3 occasions 
(day0:baseline,day1,day3). The study was carried out on two separate arms, one with l-arginine (3x7gr/d) and one with placebo 
(randomized,placebo-controlled,double-blind,cross-over design).Measurements were carried out before and 20 minutes after cigarette smoking. 
Endothelial function was evaluated by flow-mediated dilatation (FMD)of the brachial artery. Carotid-femoral pulse wave velocity (PWV) was measured 
as an index of aortic stiffness and augmentation index (AIx)as a measure of arterial wave reflections. Circulating levels of soluble intercellular cells 
adhesion molecule (s-ICAM-1) and tissue plasminogen activator (tPA) were measured by ELISA.
Results: Compared to placebo, l-arginine improved FMD(from 5.35±0.66% at day0 to 7.56±0.85,p<0.01 at day1 and 7.19±0.96,p<0.05 at 
day3). L-arginine induced a progressive decrease of PWV(from 5.02±0.19m/s at day0 to 4.72±0.19 at day1 and 4.62±0.14 at day3,both p<0.01)
and AIx(from 7.36±3.36% at day0 to 1.36±3.36 at day1 and -2.13±3.1 at day 3, both p<0.01). In day 1 and day 3, l-arginine blunted the smoking-
induced increase in AIx and PWV in no statistical significant values. Importantly, l-arginine reduced serum levels of sICAM-1 at days 1 and 3(from 
235.5ng/ml at day0 to 217 at day 1 and 219 at day 3,p<0.05 for both).Acute smoking induced a significant reduction of tPA in the placebo 
group(from 6.18±0.71ng/ml to 4.52±0.4 at day0,from 5.8±0.7 to 4.1±0.3 at day1,from 6.5±0.7 to 4.7±0.3 at day3,p<0.05 for all),while l-arginine 
prevented this effect(p=NS for all). 
Conclusion: Short-term administration of l-arginine improves endothelial function and vascular elastic properties of the arterial tree in healthy 
smokers, an effect which is accompanied by a reduction of inflammatory process and improvement of their response to smoking-induced alterations 
of fibrinolytic profile.
